0

Xstrahl participates in ASTRO 59th annual meeting

Xstrahl attended the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO) conference in San Diego, this September, the world’s largest meeting for the radiation [...]

0

Xstrahl Expands Leadership Team

Xstrahl Medical, global leaders in superficial radiotherapy devices and advanced radiation research systems, has appointed Neil Madle as Commercial Director – Radiotherapy. Based at [...]

0

Xstrahl In Action: Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials

There have been a growing number of studies combining radiotherapy with immunotherapy to enhance both local and metastatic tumor cell kill leveraging the immune-mediated abscopal effect. This [...]

0

Xstrahl In Action: Radiosensitization In Vivo by Histone Deacetylase Inhibition

As the population ages, more elderly patients require radiotherapy-based treatment for their pelvic malignancies, including muscle-invasive bladder cancer, as they are unfit for major surgery. [...]

0

Xstrahl In Action: The Erlangen Dose Optimization trial for low-dose radiotherapy of benign painful elbow syndrome

Low dose radiotherapy is being increasingly used to treat benign syndromes, however long term impact studies on these low dose radiotherapy treatments has long been neglected.   In their [...]

0

RADRES 2018; It was great! Thank you all!

Xstrahl has just returned from the 64th Annual Meeting of the Radiation Research Society in Chicago, which as usual featured some of the best of recent technology, papers and experts. We would [...]

0

RADRES 2018; It was great! Thank you all!

Xstrahl has just returned from the 64th Annual Meeting of the Radiation Research Society in Chicago, which as usual featured some of the best of recent technology, papers and experts. We would [...]

0

Looking Forward to Meeting You at ASTRO

Only a few days are left before the ASTRO’s 60th annual meeting will open its doors to more than 10,000 radiation oncology and research professionals, providing an ideal platform to discuss and [...]

0

Looking Forward to Meeting You at ASTRO

Only a few days are left before the ASTRO’s 60th annual meeting will open its doors to more than 10,000 radiation oncology and research professionals, providing an ideal platform to discuss and [...]

0

Xstrahl In Action: Radiosensitization In Vivo by Histone Deacetylase Inhibition

As the population ages, more elderly patients require radiotherapy-based treatment for their pelvic malignancies, including muscle-invasive bladder cancer, as they are unfit for major surgery. [...]

page 1 of 2